Earnings Outlook For Aytu BioPharma
Portfolio Pulse from Benzinga Insights
Aytu BioPharma (NASDAQ:AYTU) is set to release its latest quarterly earnings report on Wednesday, 2023-09-27. Analysts estimate an earnings per share (EPS) of $-0.95. The company's past performance shows a trend of missing EPS estimates, which has led to drops in share price. The last quarter saw a miss of $1.30 in EPS, followed by a 13.21% drop in share price.
September 26, 2023 | 2:02 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Aytu BioPharma's upcoming earnings report could potentially impact its stock price. Past performance shows a trend of missing EPS estimates, leading to share price drops.
Aytu BioPharma has a history of missing EPS estimates, which has consistently led to a drop in its share price. If the company misses the estimated EPS of $-0.95 in the upcoming report, it's likely that the share price will be negatively impacted.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100